MarketCap
Facebook
X
TelegramQuarterly report 2022-Q2
added 08-09-2022
Radius Health DPO Ratio 2011-2026 | RDUS
Annual DPO Ratio Radius Health
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 274 | 211 | 137 | 183 | 1.07 K | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.07 K | 137 | 375 |
Quarterly DPO Ratio Radius Health
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | 257 | 376 | - | 263 | 232 | 206 | - | 236 | 223 | 189 | - | 139 | 144 | 154 | - | - | - | - | - | - | 3.4 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 3.4 K | 139 | 485 |
DPO Ratio of other stocks in the Drug manufacturers industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Aurora Cannabis
ACB
|
-807 | $ 3.54 | 2.46 % | $ 86.3 M |  Canada |
 |
Alimera Sciences
ALIM
|
309 | - | - | $ 142 M |  USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
345 | - | 0.86 % | $ 117 M | USA |
 |
Aerie Pharmaceuticals
AERI
|
116 | - | - | $ 754 M | USA |
 |
AcelRx Pharmaceuticals
ACRX
|
58.9 | - | 7.5 % | $ 6.35 M | USA |
 |
Cronos Group
CRON
|
212 | $ 2.57 | 1.1 % | $ 1.34 B | Canada |
 |
Canopy Growth Corporation
CGC
|
52.8 | $ 1.07 | 4.9 % | $ 115 M | Canada |
 |
Agile Therapeutics
AGRX
|
352 | - | 10.11 % | $ 58.2 M | USA |
 |
Assertio Holdings
ASRT
|
122 | $ 12.34 | 4.86 % | $ 79 M | USA |
 |
DURECT Corporation
DRRX
|
519 | - | - | $ 50.1 M | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
224 | - | - | $ 2.06 B |  France |
 |
Eagle Pharmaceuticals
EGRX
|
75.6 | - | -39.89 % | $ 27.7 M | USA |
 |
Evolus
EOLS
|
59.4 | $ 5.03 | -0.2 % | $ 324 M | USA |
 |
Evoke Pharma
EVOK
|
5.36 K | - | - | $ 36.6 M | USA |
 |
Catalent
CTLT
|
41.8 | - | - | $ 11.5 B | USA |
 |
Cumberland Pharmaceuticals
CPIX
|
775 | $ 3.06 | -0.16 % | $ 43 M | USA |
 |
Jupiter Wellness
JUPW
|
215 | - | - | $ 33.6 M | USA |
 |
Athenex
ATNX
|
111 | - | -23.39 % | $ 1.76 M | USA |
 |
Endo International plc
ENDP
|
39.3 | - | - | $ 28.9 M |  Irlanda |
 |
Harrow Health
HROW
|
199 | $ 35.27 | 1.03 % | $ 1.3 B | USA |
 |
Organogenesis Holdings
ORGO
|
94 | $ 2.54 | -1.55 % | $ 334 M | USA |
 |
Pacira BioSciences
PCRX
|
37.3 | $ 21.82 | -3.83 % | $ 1.01 B | USA |
 |
Emergent BioSolutions
EBS
|
55.8 | $ 8.14 | -2.28 % | $ 417 M | USA |
 |
China Pharma Holdings
CPHI
|
33.4 | $ 0.61 | -2.26 % | $ 10.7 M |  China |
 |
Veru
VERU
|
264 | $ 2.44 | 2.74 % | $ 329 M | USA |
 |
ProPhase Labs
PRPH
|
45.4 | - | - | $ 5.07 M | USA |
 |
TherapeuticsMD
TXMD
|
723 | $ 2.26 | 4.15 % | $ 23.6 M | USA |
 |
Lannett Company
LCI
|
36.8 | - | 1.15 % | $ 7.11 M | USA |
 |
Viatris
VTRS
|
64 | $ 13.91 | 2.92 % | $ 16.7 B | USA |
 |
Perrigo Company plc
PRGO
|
64.2 | $ 10.38 | 6.79 % | $ 1.44 B | USA |
 |
Sonoma Pharmaceuticals
SNOA
|
32.3 | $ 2.44 | 1.22 % | $ 3.03 M | USA |
 |
Rockwell Medical
RMTI
|
20.9 | $ 1.06 | 10.44 % | $ 24.7 M | USA |
 |
PetIQ
PETQ
|
54.2 | - | 1.64 % | $ 400 M | USA |
 |
OptiNose
OPTN
|
194 | - | - | $ 1.08 B | USA |
 |
SCYNEXIS
SCYX
|
20.2 | $ 0.92 | 2.34 % | $ 45.9 M | USA |
 |
Recro Pharma
REPH
|
6.63 | - | -4.76 % | $ 65.3 M | USA |
 |
Tilray
TLRY
|
53 | $ 7.0 | 1.38 % | $ 4.33 B | Canada |
 |
cbdMD
YCBD
|
84 | $ 0.76 | 4.11 % | $ 3.28 M | USA |
 |
Zomedica Corp.
ZOM
|
64.3 | - | -0.21 % | $ 98 M | USA |